Cargando…
Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy
Several tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptors and molecules inhibiting the mammalian target of rapamycin are being used for management of metastatic renal cell carcinoma (mRCC); however, there is still a potential for improvement. Immune checkpoint inh...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395273/ https://www.ncbi.nlm.nih.gov/pubmed/28442891 http://dx.doi.org/10.2147/DDDT.S110209 |